Mathieu Favier
Overview
Explore the profile of Mathieu Favier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Checa-Robles F, Salvetat N, Cayzac C, Menhem M, Favier M, Vetter D, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684694
Mental health disorders are devastating illnesses, often misdiagnosed due to overlapping clinical symptoms. Among these conditions, bipolar disorder, schizophrenia, and schizoaffective disorder are particularly difficult to distinguish, as they share...
2.
Favier M, Martin Garcia E, Icick R, de Almeida C, Jehl J, Desplanque M, et al.
Nat Commun
. 2024 Jul;
15(1):5691.
PMID: 38971801
Cholinergic striatal interneurons (ChIs) express the vesicular glutamate transporter 3 (VGLUT3) which allows them to regulate the striatal network with glutamate and acetylcholine (ACh). In addition, VGLUT3-dependent glutamate increases ACh...
3.
Favier M, Carcenac C, Savasta M, Carnicella S
Curr Top Behav Neurosci
. 2022 Apr;
60:109-132.
PMID: 35469394
Parkinson's disease (PD), which is traditionally viewed as a motor disorder involving the degeneration of dopaminergic (DA) neurons, has recently been identified as a quintessential neuropsychiatric condition. Indeed, a plethora...
4.
El Mestikawy S, Favier M
Med Sci (Paris)
. 2021 Sep;
37(8-9):719-721.
PMID: 34491179
No abstract available.
5.
Favier M, Pietrancosta N, El Mestikawy S, Gangarossa G
Trends Pharmacol Sci
. 2021 Mar;
42(6):475-490.
PMID: 33775453
Vesicular glutamate transporters (VGLUTs) were long thought to be specific markers of glutamatergic excitatory transmission. The discovery, two decades ago, of the atypical VGLUT3 has thoroughly modified this oversimplified view....
6.
Favier M, Janickova H, Justo D, Kljakic O, Runtz L, Natsheh J, et al.
J Clin Invest
. 2020 Nov;
130(12):6616-6630.
PMID: 33164988
Dysregulation of habit formation has been recently proposed as pivotal to eating disorders. Here, we report that a subset of patients suffering from restrictive anorexia nervosa have enhanced habit formation...
7.
Smart K, Nagano-Saito A, Milella M, Sakae D, Favier M, Vigneault E, et al.
J Psychiatry Neurosci
. 2020 Jun;
46(1):E1-E13.
PMID: 32559027
Background: Glutamate transmission is implicated in drug-induced behavioural sensitization and the associated long-lasting increases in mesolimbic output. Metabotropic glutamate type 5 (mGlu5) receptors might be particularly important, but most details...
8.
Favier M, Carcenac C, Savasta M, Carnicella S
Med Sci (Paris)
. 2017 Oct;
33(10):822-824.
PMID: 28994369
No abstract available.
9.
Favier M, Carcenac C, Drui G, Vachez Y, Boulet S, Savasta M, et al.
Sci Rep
. 2017 Jan;
7:41589.
PMID: 28134302
Beyond classical motor symptoms, motivational and affective deficits are frequently observed in Parkinson's disease (PD), dramatically impairing the quality of life of patients. Using bilateral 6-hydroxydopamine (6-OHDA) lesions of the...
10.
Carcenac C, Favier M, Vachez Y, Lacombe E, Carnicella S, Savasta M, et al.
Mov Disord
. 2015 Jan;
30(13):1739-49.
PMID: 25588931
High-frequency stimulation (HFS) of the subthalamic nucleus (STN) is recognized as an effective treatment for the motor symptoms of Parkinson's disease (PD), but its mechanisms, particularly as concern dopaminergic transmission,...